| Sanofi-Aventis (Suisse) SA - Fasturtec 7.5 mg / 5 ml, poudre et solvant pour solution à diluer pour perfusion |
| 55789 | | 02 | | Fasturtec 7.5 mg / 5 ml | | poudre et solvant pour solution à diluer pour perfusion | | V03AF07 | | Rasburicase | | 15.04.2003 | | |
|
| Composition |
| Praeparatio sicca: rasburicasum 7.5 mg, alaninum, mannitolum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dodecahydricus, pro vitro corresp. natrium max. 10.5 mg.
Solvens: poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 5 ml. |
| Packungsbestandteile |
| Solvens | | Injection preparation | | | | | | | | | Inactive agents | Dose |
|---|
| Poloxamer | 188 |
|
| poudre et solvant pour solution à diluer pour perfusion | | | | | | Active Agent | Dose | additional_information |
|---|
| Rasburicase | 7.5 mg | Praeparatio sicca |
| | | | Inactive agents |
|---|
| Alanine | | Disodium Phosphate Dihydrate | | Disodium Phosphate Dodecahydrate | | Mannitol | | Sodium Dihydrogenophosphate Dihydrate |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | Kombipackung(en) à 7.5 mg | PR | PR | A | | Yes |
|
